ID: ALA4518214

Max Phase: Preclinical

Molecular Formula: C18H27NO2

Molecular Weight: 289.42

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cccc(CCCCCCC(=O)N2CCCC2)c1

Standard InChI:  InChI=1S/C18H27NO2/c1-21-17-11-8-10-16(15-17)9-4-2-3-5-12-18(20)19-13-6-7-14-19/h8,10-11,15H,2-7,9,12-14H2,1H3

Standard InChI Key:  VXOXAQBFTNGRDN-UHFFFAOYSA-N

Associated Targets(non-human)

N-acylethanolamine-hydrolyzing acid amidase 372 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 289.42Molecular Weight (Monoisotopic): 289.2042AlogP: 3.81#Rotatable Bonds: 8
Polar Surface Area: 29.54Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.72CX LogD: 3.72
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.68Np Likeness Score: -0.60

References

1. Zhou P, Xiang L, Zhao D, Ren J, Qiu Y, Li Y..  (2019)  Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors.,  10  (2): [PMID:30931090] [10.1039/C8MD00432C]

Source